Accretion Nutraveda IPO GMP ₹70 Today (15 Oct), Price Band, Subscription Status, Allotment Date

Accretion Nutraveda IPO Review & Analysis

Our reading of the numbers below — growth rates, margins, pricing and demand are calculated from the company's own filed figures, not copied from anywhere.

Accretion Nutraveda is an SME issue raising ₹24.77 Crores, offered in a band of ₹122–₹129 per share. At the upper end that is 12.9 times the ₹10 face value, so ₹119 of every share subscribed is share premium rather than capital. SME issues list on the BSE SME or NSE Emerge platform rather than the main board. They trade in fixed lots after listing, carry no retail-versus-HNI cut-off bidding, and are usually far less liquid, so exiting a position can take longer than on the main board.

A retail application for Accretion Nutraveda needs one lot of 2000 shares, which works out to ₹2,58,000 at the upper band of ₹129. SME lots are deliberately sized above ₹1,00,000, so this is a far larger single commitment than a mainboard application and rules out most small investors. Retail applications are capped at ₹2,00,000, which here is a single lot; bidding above that moves the application into the non-institutional category, and the large-HNI bucket begins at ₹10,00,000, or about 4 lots.

For Accretion Nutraveda, bidding runs 28-30 January, allotment is finalised on 2 Feb 2026, the shares list on 4 Feb 2026. Applications that do not receive an allotment have their UPI mandate released around 3 days after the issue closes. Counting from the close of bidding, money stays blocked for roughly 5 days before listing decides what the holding is worth.

The issue is reserved 47.29% to qualified institutional buyers, 14.37% to non-institutional investors, 33.33% to retail. At 33.33%, the retail portion is on the narrower side, so retail allotment turns into a lottery quickly once the book fills. An oversubscribed retail portion is not allotted in proportion to the amount applied for: applications are reduced to single lots and drawn by lot, so several small applications from different PANs are more effective than one large one.

Subscription stands at 0.68x, which is below full. An issue must be subscribed at least once over to proceed at all; if it closes under that, the offer is withdrawn and all application money is refunded.

KFin Technologies Pvt. Ltd. is the registrar for this issue, which means the allotment status for Accretion Nutraveda is published on their portal from 2 Feb 2026. A PAN, application number or demat client ID is enough to look it up; the credited shares also appear in the demat account itself a day or so before listing.

A grey market premium of ₹70 on the upper band of ₹129 implies a listing gain of roughly 54.3%. The grey market is unofficial and unregulated, the premium can change daily, and it has no bearing on allotment — treat it as a sentiment reading, not a forecast.

The figures above are worked out from the issue's own filed numbers and are for information only. They are not investment advice — read the RHP before you apply.